CPH Group Focuses on Growth Amidst Market Challenges

CPH Group has outlined its growth strategy after an Investors' Meeting on 9 November 2026 in Zurich. The company emphasizes its strategic priorities in the Perlen Packaging and Zeochem divisions, focusing on expanding high-value product portfolios and improving global market presence. Key growth initiatives include enhancing pharmaceutical packaging and chromatography gels, emphasizing the integration of recent acquisitions to support profitable growth.

For FY2026, CPH anticipates slight sales and EBITDA growth, with stable EBIT and net results, dependent on stable exchange rates and geopolitical stability. Notably, the Packaging division shows promising sales and profitability improvements, offsetting challenges in Chemistry.

CPH reaffirms mid-term financial targets, expecting 5%-8% annual sales growth and an attractive dividend payout. Valuation sees CPH with potential for significant share price appreciation, benefiting from structural healthcare and energy growth despite market challenges.